688236 春立医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.9974.3889.92711.86118.168
总资产报酬率 ROA (%)3.2923.5137.8719.60214.196
投入资产回报率 ROIC (%)3.8274.1689.49411.50417.405

边际利润分析
销售毛利率 (%)67.08966.62572.47676.02677.115
营业利润率 (%)26.11016.22125.31827.37233.172
息税前利润/营业总收入 (%)24.72714.21223.94026.35732.283
净利润/营业总收入 (%)23.47915.46922.98825.60929.090

收益指标分析
经营活动净收益/利润总额(%)120.82096.97296.94697.282102.731
价值变动净收益/利润总额(%)5.90115.5137.0694.8200.000
营业外收支净额/利润总额(%)-0.0010.672-0.0232.366-0.058

偿债能力分析
流动比率 (X)5.8925.1954.4414.6645.568
速动比率 (X)4.7294.1883.7994.2285.205
资产负债率 (%)16.61618.59321.10720.23817.688
带息债务/全部投入资本 (%)0.5971.4362.2050.022-0.978
股东权益/带息债务 (%)16,117.6046,635.7274,295.122443,917.517-9,959.518
股东权益/负债合计 (%)501.580437.607373.539394.121465.354
利息保障倍数 (X)-17.880-6.710-17.448-15.698-37.101

营运能力分析
应收账款周转天数 (天)88.842139.503133.250133.163100.950
存货周转天数 (天)624.448659.443375.695262.096233.015